Benzodiazepine: Difference between revisions
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
{{TOC|right}} | {{TOC|right}} | ||
In [[pharmacology]], '''benzodiazepines''' are a class of [[medication]]s that are "a group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring."<ref>{{MeSH}}</ref> All benzodiazepines affect specific benzodiazepine receptors and modulate [[gamma-aminobutyric acid]]. Specific benzodiazepines also affect other neurotransmitters (e.g., [[clonazepam]] and [[alprazolam]] affect [[serotonin]]). Receptor relationships are quite complex and are discussed further below. | In [[pharmacology]], '''benzodiazepines (BZD)''' are a class of [[medication]]s that are "a group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring."<ref>{{MeSH}}</ref> All benzodiazepines affect specific benzodiazepine receptors and modulate [[gamma-aminobutyric acid]]. Specific benzodiazepines also affect other neurotransmitters (e.g., [[clonazepam]] and [[alprazolam]] affect [[serotonin]]). Receptor relationships are quite complex and are discussed further below. | ||
Uses include the treatment of [[anxiety disorder]]s and [[alcohol withdrawal syndrome]]. Some are used as [[anticonvulsant]]s and to treat [[musculoskeletal spasticity]]. | Uses include the treatment of [[anxiety disorder]]s and [[alcohol withdrawal syndrome]]. Some are used as [[anticonvulsant]]s and to treat [[musculoskeletal spasticity]]. Examples are: | ||
{{col-begin}} | |||
Examples are: | {{col-break|width=50%}} | ||
{| | |||
|- valign=top | |||
| | |||
* Alprazolam | * Alprazolam | ||
* Benzodiazepinones | * Benzodiazepinones | ||
** Bromazepam | ** Bromazepam | ||
** [[Clonazepam]] | ** [[Clonazepam]] | ||
| Line 22: | Line 24: | ||
** Prazepam | ** Prazepam | ||
** Temazepam | ** Temazepam | ||
{{col-break|width=50%}} | |||
* [[Chlordiazepoxide]] (Librium) | * [[Chlordiazepoxide]] (Librium) | ||
* Clorazepate dipotassium | * Clorazepate dipotassium | ||
| Line 28: | Line 31: | ||
* [[Midazolam]] (Versed) | * [[Midazolam]] (Versed) | ||
* Triazolam | * Triazolam | ||
|} | |||
==Receptors== | ==Receptors== | ||
Part of the confusion in the receptors they affect come from the observation that what had previously been considered the GABA<sub>A</sub>-benzodiazepine-Cl<sup>-</sup> channel complex receptor has numerous sub-receptors, in five classes (α, β, γ, δ, ρ) with at least 16 subtypes. Benzodiazepine receptor type 1, for example, involves binding to α<sub>1</sub>, β<sub>2</sub> and γ<sub>2</sub>.<ref name=GG>{{citation | Part of the confusion in the receptors they affect come from the observation that what had previously been considered the GABA<sub>A</sub>-benzodiazepine-Cl<sup>-</sup> channel complex receptor has numerous sub-receptors, in five classes (α, β, γ, δ, ρ) with at least 16 subtypes. Benzodiazepine receptor type 1, for example, involves binding to α<sub>1</sub>, β<sub>2</sub> and γ<sub>2</sub>.<ref name=GG>{{citation | ||
| Line 44: | Line 48: | ||
| publisher = eMedicine | | publisher = eMedicine | ||
| url = http://emedicine.medscape.com/article/813255-overview}}</ref> potentiating the effect of both endogenous GABA and GABA released by direct GABA agonists such as [[baclofen]]. | | url = http://emedicine.medscape.com/article/813255-overview}}</ref> potentiating the effect of both endogenous GABA and GABA released by direct GABA agonists such as [[baclofen]]. | ||
There can be synergism in the use of various drugs that affect GABA. In musculoskeletal spasticity, as in [[multiple sclerosis]] or various disorders of spinal nerves, the first antispasticity drug prescribed is usually the GABA agonist [[baclofen]], but it may be supplemented the BZD [[diazempam]]; diazepam can also be used as an alternative. In one study, the GABA agonists [[baclofen]] and [[muscimol]] were potentiated pain relief in rats when combined with the benzodiazepine [[diazepam]]. <ref>{{citation | |||
| title = The Interaction Between Gamma-Aminobutyric Acid Agonists and Diltiazem in Visceral Antinociception in Rats | |||
| author = Kaoru Hara ''et al.'' | |||
| doi= 10.1213/ 01.ANE.0000107935.84035.48 | |||
| journal = Anesthesia and Analgesia | |||
| date = May 2004 | |||
| volume = 98 | issue = 5 | pages = 1380-1384 | |||
| url = http://www.anesthesia-analgesia.org/content/98/5/1380.full| }}</ref> | |||
==Clinical use== | ==Clinical use== | ||
===Anxiety=== | ===Anxiety=== | ||
Revision as of 15:36, 4 June 2010
In pharmacology, benzodiazepines (BZD) are a class of medications that are "a group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring."[1] All benzodiazepines affect specific benzodiazepine receptors and modulate gamma-aminobutyric acid. Specific benzodiazepines also affect other neurotransmitters (e.g., clonazepam and alprazolam affect serotonin). Receptor relationships are quite complex and are discussed further below.
Uses include the treatment of anxiety disorders and alcohol withdrawal syndrome. Some are used as anticonvulsants and to treat musculoskeletal spasticity. Examples are:
ReceptorsPart of the confusion in the receptors they affect come from the observation that what had previously been considered the GABAA-benzodiazepine-Cl- channel complex receptor has numerous sub-receptors, in five classes (α, β, γ, δ, ρ) with at least 16 subtypes. Benzodiazepine receptor type 1, for example, involves binding to α1, β2 and γ2.[2] The interactions among GABA, benzodiazepines, and some other classes of drugs are even more complex, in that binding to one receptor type affects other receptors. For example, certain bindings to benzodiazepine receptors will increase the rate of opening of the GABAA receptor,[3] potentiating the effect of both endogenous GABA and GABA released by direct GABA agonists such as baclofen. There can be synergism in the use of various drugs that affect GABA. In musculoskeletal spasticity, as in multiple sclerosis or various disorders of spinal nerves, the first antispasticity drug prescribed is usually the GABA agonist baclofen, but it may be supplemented the BZD diazempam; diazepam can also be used as an alternative. In one study, the GABA agonists baclofen and muscimol were potentiated pain relief in rats when combined with the benzodiazepine diazepam. [4] Clinical useAnxietyConvulsive disordersMusculoskeletal spasticityToxicity and abuseReferences
|